Welcome to our dedicated page for Ingredion SEC filings (Ticker: INGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingredion Incorporated filings document the formal disclosures of a NYSE-listed ingredient solutions company with common stock registered under the ticker INGR. Its 8-K reports include operating results, financial-condition updates, dividend-related corporate actions, leadership changes, board appointments and governance matters.
The company's proxy materials cover director elections, executive compensation, board structure, shareholder voting items and non-management director compensation. Other filings describe capital-structure details for its common stock, exit or disposal activities, impairment charges, restructuring matters and risk disclosures connected to manufacturing operations and the company's plant-based ingredient portfolio.
Ingredion Inc (INGR) announced that its board elected Diego Reynoso as Executive Vice President and Chief Financial Officer, effective October 1, 2026. At that time he will become the company’s principal financial officer, and Jason Payant will revert from Interim Chief Financial Officer to Vice President, Finance, Global Texture & Healthful Solutions.
Reynoso, age 51, brings over 25 years of finance and operations experience from Boston Beer, Tyson Foods, Constellation Brands, Beam Suntory and others. His compensation package includes a $725,000 base salary, an annual bonus target equal to 90% of salary, a $770,000 time-based sign-on cash award, and sign-on equity grants valued at $1.3 million and $700,000. Beginning in 2027, his targeted annual long-term incentive grant value is $1.6 million, delivered in a mix of performance share units and restricted stock units, with pro rata vesting protection on 2026–2028 equity awards in the event of certain involuntary terminations.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc (INGR) reported that officer David Eric Seip, SVP, Global Ops and CSCO, received an award of 16.6010 units of Phantom Stock on August 14, 2026. The units are allocated under a Non-Qualified Deferred Compensation Plan and are based on a reference price of $105.20 per share. Following this award, Seip holds a total of 13,394.4941 Phantom Stock units, each representing the right to receive one share of common stock.
Ingredion Inc executive Michael J. Leonard, SVP, CIO & Head of Protein Fortification, reported an acquisition of 32.470 phantom stock units on August 14, 2026. These units were allocated under a Non-Qualified Deferred Compensation Plan, bringing his total phantom stock holdings to 1,833.948 units, each representing the right to receive one share of common stock.
Ingredion reported Q2 2026 net sales of $1.85 billion, up slightly year over year, but operating income declined to $188 million and net income attributable to Ingredion to $114 million ($1.78 diluted EPS) as higher manufacturing costs, a thermal event at its Argo facility, and $45 million of restructuring and impairment charges reduced margins.
For the first half of 2026, net sales were $3.64 billion, operating income $391 million, and net income attributable to Ingredion $256 million ($4.01 diluted EPS), all below 2025, reflecting $56 million of restructuring and impairment (including closure of the Cabo, Brazil facility) and $47 million of acquisition‑related foreign‑exchange hedging losses, partly offset by a $44 million gain on the sale of a majority stake in the Pakistan business.
Ingredion agreed to acquire Tate & Lyle PLC for approximately £2.7 billion (about $3.5 billion), funded with cash, new debt and committed facilities including a $2.75 billion bridge loan and a $1.48 billion delayed‑draw term loan. Tate & Lyle shareholders have approved the court‑sanctioned scheme of arrangement, with completion targeted for the second half of 2027, subject to court and regulatory approvals.
Ingredion ended June 30, 2026 with $948 million of cash and cash equivalents, total debt of $1.78 billion, and stated available liquidity of about $3.9 billion, providing capacity to fund operations, dividends, capital spending and the planned Tate & Lyle transaction.
Ingredion Inc director David B. Fischer sold 1,662 shares of common stock on 2026-08-05 at a weighted average price of $102.31 per share, in multiple trades between $102.13 and $102.55. After this sale, he directly owned 19,929.8698 shares, including RSUs from deemed dividend reinvestment.
Ingredion Incorporated reported second quarter 2026 net sales of $1.85 billion, up 1% year over year, while reported operating income fell 31% to $188 million and adjusted operating income declined 5% to $258 million. Reported diluted EPS decreased to $1.78 from $2.99, with adjusted EPS slipping slightly to $2.82 from $2.87.
Results reflected restructuring and impairment charges tied to the closure of the Cabo, Brazil facility, costs related to a thermal event at the Argo plant, and a $47 million mark-to-market foreign exchange loss on derivatives hedging the pending Tate & Lyle acquisition. Texture & Healthful Solutions delivered 5% net sales and operating income growth to $627 million and $117 million, while Food & Industrial Ingredients–LATAM and –U.S./CAN saw operating income declines of 7% and 33%, respectively, amid currency pressure, softer demand, and earlier Argo production issues that had normalized by quarter-end. The company completed the sale of a majority stake in its Pakistan business, generating a $44 million gain but reducing second-half earnings contribution. For full-year 2026, management reaffirmed guidance for reported EPS of $9.15–$9.75 and adjusted EPS of $10.30–$10.90, expects net sales to be flat to up low single digits, and projects cash from operations of $700–$800 million and capital expenditures of $450–$490 million.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc SVP, Global Ops and CSCO David Eric Seip reported a grant of 17.5600 phantom stock units on July 31, 2026 as a derivative award. These units are allocated under the Non-Qualified Deferred Compensation Plan at the $99.458 closing share price. After this award, he holds 13,377.8931 phantom stock units, each representing the right to receive one share of common stock, including units accumulated through dividend reinvestment.
Ingredion Inc executive Michael J. Leonard, SVP, CIO & Head of Protein Fortification, reported an allocation of 34.343 phantom stock units on July 31, 2026 under the Non-Qualified Deferred Compensation Plan, valued using the $99.462 closing share price. After this report, his phantom stock holdings total 1,801.478 units, including units acquired through dividend reinvestment. Each phantom stock unit represents the right to receive one share of common stock.
First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation report their beneficial ownership of Ingredion Incorporated common stock in an amended Schedule 13G. The group reports beneficial ownership of 2,198,157 shares, representing 3.49% of the outstanding class as of the reporting date.
The filers report no sole voting or dispositive power. They report shared voting power over 1,446,843 shares and shared dispositive power over 2,198,157 shares, largely held in unit investment trusts and other client accounts. Each entity disclaims beneficial ownership of the reported shares, and the filing is made jointly under Rule 13d-1(k)(1). The position is explicitly described as ownership of 5 percent or less of the class.